Extra-neural metastases of malignant gliomas: myth or reality?
- PMID: 24212625
- PMCID: PMC3756372
- DOI: 10.3390/cancers3010461
Extra-neural metastases of malignant gliomas: myth or reality?
Abstract
Malignant gliomas account for approximately 60% of all primary brain tumors in adults. Prognosis for these patients has not significantly changed in recent years-despite debulking surgery, radiotherapy and cytotoxic chemotherapy-with a median survival of 9-12 months. Virtually no patients are cured of their illness. Malignant gliomas are usually locally invasive tumors, though extra-neural metastases can sometimes occur late in the course of the disease (median of two years). They generally appear after craniotomy although spontaneous metastases have also been reported. The incidence of these metastases from primary intra-cranial malignant gliomas is low; it is estimated at less than 2% of all cases. Extra-neural metastases from gliomas frequently occur late in the course of the disease (median of two years), and generally appear after craniotomy, but spontaneous metastases have also been reported. Malignant glioma metastases usually involve the regional lymph nodes, lungs and pleural cavity, and occasionally the bone and liver. In this review, we present three cases of extra-neural metastasis of malignant gliomas from our department, summarize the main reported cases in literature, and try to understand the mechanisms underlying these systemic metastases.
Figures
References
-
- Behin A., Hoang-Xuan K., Carpentier A.F., Delattre J.Y. Primary brain tumours in adults. Lancet. 2003;361:323–331. - PubMed
-
- Black P.M. Brain tumors. Part 1. N. Engl. J. Med. 1991;324:1471–1476. - PubMed
-
- Black PM. Brain tumors. Part 2. N. Engl. J. Med. :1555–1564. - PubMed
-
- DeAngelis LM. Brain tumors. N. Engl. J. Med. 2001;344:114–123. - PubMed
-
- Stupp R., Hegi M., Mason WP., van den Bent MJ., Taphoorn M., Belanger K., Brandes AA., Maroisi C., Bogdahn U., Curschmann J., Janzer RC., Ludwin SL., Gorlia T., Allgeier A., Lacombe D., Cairncross G., Eisenhauer E., Mirimanoff R.O. Effects of of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomized phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10:459–466. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
